|By PR Newswire||
|August 25, 2014 03:10 AM EDT||
AACHEN, Germany, August 25, 2014 /PRNewswire/ --
Chronic pain patients benefit from long-term tapentadol treatment
A recent study published in the medical journal "Current Medical Research and Opinion"* has results that are good news for chronic pain patients.
This new trial was designed to meet real-life conditions in the treatment of severe chronic pain and included also a group with 588 chronic pain patients that were treated over 12 months. By using tapentadol prolonged release (PR) (Palexia®), more than half of these patients experienced a major reduction of pain intensity (by at least 50%). The proportion of patients with pain-free intervals rose from about 8 to 24% and the number of patients with uninterrupted sleep rose from approximately 9 to 35%.
At the end of the observation, about 89% of patients had reached or exceeded their individual treatment target.
The author, a pain specialist, concluded that tapentadol therapy provides stable pain relief for at least one year. The high efficiency and good tolerability confirm that tapentadol PR is a valuable alternative to classical strong opioids for the long-term management of chronic pain.
You can access the publication for free at http://informahealthcare.com/doi/full/10.1185/03007995.2014.939166
*Strick et al. 2014 Current Medical Research & Opinion posted online on July 15, 2014. (doi:10.1185/03007995.2014.939166)
The Grünenthal Group is an independent, family-owned, international research-based pharmaceutical company headquartered in Aachen, Germany. Building on its unique position in pain treatment, its objective is to become the most patient-centric company in the field of pain and thus to be a leader in therapy innovation.
Grünenthal is one of the last five remaining research-oriented pharmaceutical companies with headquarters in Germany which sustainably invests in research and development. Research and development costs amounted to about 27 percent of revenues in 2013. Grünenthal's research and development strategy concentrates on selected fields of therapy and state-of-the-art technologies. We are intensely focused on discovering new ways to treat pain better and more effectively, with fewer side-effects than current therapies.
Altogether, the Grünenthal Group has affiliates in 25 countries worldwide. Grünenthal products are sold in more than 155 countries and approx. 5,500 employees are working for the Grünenthal Group worldwide. In 2013, Grünenthal achieved revenues of €901 mn.
More information: http://www.grunenthal.com
Jeanette Hübsch, Head of Brand Communication Palexia
Grünenthal Europe & Australia
Email: [email protected]
Cloud computing is being adopted in one form or another by 94% of enterprises today. Tens of billions of new devices are being connected to The Internet of Things. And Big Data is driving this bus. An exponential increase is expected in the amount of information being processed, managed, analyzed, and acted upon by enterprise IT. This amazing is not part of some distant future - it is happening today. One report shows a 650% increase in enterprise data by 2020. Other estimates are even higher....
Sep. 30, 2016 08:00 AM EDT Reads: 4,218
An IoT product’s log files speak volumes about what’s happening with your products in the field, pinpointing current and potential issues, and enabling you to predict failures and save millions of dollars in inventory. But until recently, no one knew how to listen. In his session at @ThingsExpo, Dan Gettens, Chief Research Officer at OnProcess, will discuss recent research by Massachusetts Institute of Technology and OnProcess Technology, where MIT created a new, breakthrough analytics model f...
Sep. 30, 2016 08:00 AM EDT Reads: 2,149
Personalization has long been the holy grail of marketing. Simply stated, communicate the most relevant offer to the right person and you will increase sales. To achieve this, you must understand the individual. Consequently, digital marketers developed many ways to gather and leverage customer information to deliver targeted experiences. In his session at @ThingsExpo, Lou Casal, Founder and Principal Consultant at Practicala, discussed how the Internet of Things (IoT) has accelerated our abil...
Sep. 30, 2016 08:00 AM EDT Reads: 2,818
SYS-CON Events announced today that Niagara Networks will exhibit at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. Niagara Networks offers the highest port-density systems, and the most complete Next-Generation Network Visibility systems including Network Packet Brokers, Bypass Switches, and Network TAPs.
Sep. 30, 2016 08:00 AM EDT Reads: 558
Sep. 30, 2016 08:00 AM EDT
Sep. 30, 2016 07:30 AM EDT
Sep. 30, 2016 07:15 AM EDT Reads: 3,268
Sep. 30, 2016 07:15 AM EDT Reads: 2,241
Sep. 30, 2016 07:00 AM EDT Reads: 3,465
Sep. 30, 2016 07:00 AM EDT Reads: 2,337
Sep. 30, 2016 07:00 AM EDT Reads: 1,507
Sep. 30, 2016 06:15 AM EDT Reads: 1,129
Sep. 30, 2016 06:00 AM EDT Reads: 1,261
Sep. 30, 2016 06:00 AM EDT Reads: 2,736
Sep. 30, 2016 05:30 AM EDT Reads: 1,284